General Practitioner News and Research

RSS

Short-listed companies to submit proposals for chronic disease management system

eHealth Ontario and Infrastructure Ontario today announced the three companies short-listed to submit proposals for a chronic disease management system that will be used initially to establish a Diabetes Registry for Ontarians and an eHealth Portal framework.

22 Oct 2009

Study reveals the increasing demand for alternative medical therapies to treat CRS

A new study suggests that a growing segment of patients are turning to complementary and alternative medical therapies to help treat the symptoms of chronic rhinosinusitis (CRS).

4 Oct 2009

New website offers personalized advice on H1N1

Researchers at the University of Southampton have developed a new website which gives personalised advice on coping with swine flu and other cold and flu symptoms.

1 Oct 2009

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

25 Sep 2009

2009 IOF-AMGEN Health Professional Awareness Grants aim to raise osteoporosis awareness

Presented today at the International Osteoporosis Foundation's (IOF) Worldwide Conference of Osteoporosis Patient Societies in Beijing, the 2009 IOF-AMGEN Health Professional Awareness Grants aim to support innovative and cost effective projects by IOF member societies that focus on improving knowledge and raising awareness of osteoporosis among clinicians and allied health professionals.

25 Sep 2009

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

22 Sep 2009

Patients with higher levels of vitamin D are less likely to die from skin cancer

New research shows higher levels of vitamin D may help improve survival for both bowel and skin cancer patients.

22 Sep 2009

Many Australians at risk of having a heart attack are not receiving the best possible care: Study

The research suggests that GPs are still managing individual risk factors such as blood pressure and cholesterol in isolation of one another, and are not adopting recommendations to treat a patient's overall or absolute risk. Absolute risk management is based on the principle that the major risk factors for cardiovascular disease act together. By taking this approach treatment can be targeted to those most likely to benefit.

21 Sep 2009

Researchers study about GP's gut feelings

'Gut feelings' experienced by GPs play a substantial role in their diagnostic reasoning process, but always in combination with analytical reasoning. Gut feelings can be separated into the sense of alarm and the sense of reassurance.

17 Sep 2009

Researchers achieve positive results from a sustainable intervention in the primary care practice

German researchers from the Institutes for General Practice in Frankfurt / Main and Jena have achieved positive results from a sustainable intervention in the primary care practice (Annals of Internal Medicine, volume 151, number 6, Sep. 15, 2009).

17 Sep 2009

Individuals with upper-GI symptoms visit general practitioners often

Patients with upper gastrointestinal (GI) complaints visit their general practitioner (GP) more often than patients with other conditions. Researchers writing in the open access journal BMC Family Practice found that people with dyspepsia, heartburn, epigastric discomfort and other upper-abdominal complaints had almost twice as many GP contacts, which were ultimately associated with problems in all organ systems.

9 Sep 2009

Increased public awareness of cancer symptoms necessary to prevent avoidable deaths

One in seven people cannot name a single symptom of cancer, according to a Cancer Research UK survey published today (Monday).

8 Sep 2009

Contraceptive pill likely cause for 20 percent drop in ovarian cancer rates

Ovarian cancer rates have fallen by almost 20 per cent in a decade, according to Cancer Research UK today (Wednesday).

8 Sep 2009

People with genetic risk of bowel cancer decline genetic testing

An Australian study of families with genetic risk of bowel cancer has found that 50 percent of participants declined genetic testing when informed of insurance implications.

7 Sep 2009

UK Performance Network signs agreements with South West and thirteen PCTs

The UK Performance Network announced it has signed agreements with the South West Strategic Health Authority and thirteen primary care trusts (PCTs) in the South West as new subscribers.

3 Sep 2009

Accumetrics signs a distribution agreement with Grifols for its VerifyNow System in Spain, Portugal and Chile

Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.

2 Sep 2009

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.

31 Aug 2009

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

25 Aug 2009

University of Southampton develops a microfluidic single-cell impedance cytometer for blood cell analysis

A hand-held device which could offer point-of-care blood cell analysis in doctors' surgeries is being developed by academics at the University of Southampton and is described in a paper in Lab on a Chip this month.